BD Pharmingen- PE Rat Anti-Mouse PIR-A-B_BD Pharmingen
参考图片
Two-color analysis of the expression of PIR-A/B on mouse spleen cells. BALB/c splenocytes were preincubated with Mouse BD Fc Block™ (Cat. no. 553141/553142) and simultaneously stained with PE- conjugated 6C1 (both panels) and either FITCconjugated 1D3 (anti-mouse CD19, Cat. no. 557398/553785, left panel) or FITC- conjugated M1/70 (anti-mouse CD11b, Cat. no. 557396/553310, right panel) monoclonal antibodies. Left panel demonstrates that the majority of B lymphocytes (CD19-positive cells) express intermediate levels of PIR- A/B, while the right panel shows that most myeloid cells (CD11b- or Mac-1-positive) express high levels of PIR-A/B. Flow cytometry was performed on a BD FACScan™ Flow Cytometry System. The quadrant positions are based upon analyses of isotype controls.
Two-color analysis of the expression of PIR-A/B on mouse spleen cells. BALB/c splenocytes were preincubated with Mouse BD Fc Block™ (Cat. no. 553141/553142) and simultaneously stained with PE- conjugated 6C1 (both panels) and either FITCconjugated 1D3 (anti-mouse CD19, Cat. no. 557398/553785, left panel) or FITC- conjugated M1/70 (anti-mouse CD11b, Cat. no. 557396/553310, right panel) monoclonal antibodies. Left panel demonstrates that the majority of B lymphocytes (CD19-positive cells) express intermediate levels of PIR- A/B, while the right panel shows that most myeloid cells (CD11b- or Mac-1-positive) express high levels of PIR-A/B. Flow cytometry was performed on a BD FACScan™ Flow Cytometry System. The quadrant positions are based upon analyses of isotype controls.
本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/kangti/8660.html